Quercetin and Nf-kB / AP-1 induced apoptosis

No Pathway Network information available for Quercetin and Nf-kB / AP-1 induced apoptosis

Pathways in the Quercetin and Nf-kB / AP-1 induced apoptosis SuperPath

#	Name	Source	Genes
1	Quercetin and Nf-kB / AP-1 induced apoptosis	WikiPathways	ACOX2 CYP2A6 FOS IKBKB JUN KEAP1 MAFG MAFK MMP1 MT-CO1 NFE2L2 NFKB1 NFKBIA NOS1 PTGS2 VEGFA (see all 16) (see less)

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	KEAP1	Kelch Like ECH Associated Protein 1	Protein Coding	1
2	ACOX2	Acyl-CoA Oxidase 2	Protein Coding	1
3	VEGFA	Vascular Endothelial Growth Factor A	Protein Coding	1
4	PTGS2	Prostaglandin-Endoperoxide Synthase 2	Protein Coding	1
5	NOS1	Nitric Oxide Synthase 1	Protein Coding	1
6	NFKBIA	NFKB Inhibitor Alpha	Protein Coding	1
7	NFKB1	Nuclear Factor Kappa B Subunit 1	Protein Coding	1
8	NFE2L2	NFE2 Like BZIP Transcription Factor 2	Protein Coding	1
9	MT-CO1	Mitochondrially Encoded Cytochrome C Oxidase I	Protein Coding	1
10	MMP1	Matrix Metallopeptidase 1	Protein Coding	1
11	MAFG	MAF BZIP Transcription Factor G	Protein Coding	1
12	JUN	Jun Proto-Oncogene, AP-1 Transcription Factor Subunit	Protein Coding	1
13	IKBKB	Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta	Protein Coding	1
14	FOS	Fos Proto-Oncogene, AP-1 Transcription Factor Subunit	Protein Coding	1
15	CYP2A6	Cytochrome P450 Family 2 Subfamily A Member 6	Protein Coding	1
16	MAFK	MAF BZIP Transcription Factor K	Protein Coding	1

Disorders associated with Quercetin and Nf-kB / AP-1 induced apoptosis SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Lung cancer	Enrichment	CYP2A6, NFE2L2	3.20
2	Pyloric stenosis, infantile hypertrophic, 1	Enrichment	NOS1	2.93
3	Myoglobinuria, recurrent	Enrichment	MT-CO1	2.93
4	Immunodeficiency 15b	Enrichment	IKBKB	2.93
5	Bile acid synthesis defect, congenital, 6	Enrichment	ACOX2	2.93
6	Immunodeficiency 15a	Enrichment	IKBKB	2.93
7	Immunodeficiency, developmental delay, and hypohomocysteinemia	Enrichment	NFE2L2	2.93
8	Microvascular complications of diabetes 1	Enrichment	VEGFA	2.93
9	Letrozole toxicity	Enrichment	CYP2A6	2.93
10	Ectodermal dysplasia and immunodeficiency 2	Enrichment	NFKBIA	2.63
11	Goiter, multinodular 1, with or without sertoli-leydig cell tumors	Enrichment	KEAP1	2.63
12	Immunodeficiency, common variable, 12, with autoimmunity	Enrichment	NFKB1	2.63
13	Recessive dystrophic epidermolysis bullosa	Enrichment	MMP1	2.63
14	Ectodermal dysplasia and immune deficiency	Enrichment	NFKBIA	2.63
15	Common variable immunodeficiency 12	Enrichment	NFKB1	2.63
16	Keratoderma, palmoplantar, with deafness	Enrichment	MT-CO1	2.45
17	Nasopharyngeal carcinoma	Enrichment	NFKBIA	2.45
18	Coumarin resistance	Enrichment	CYP2A6	2.45
19	Myelodysplastic syndrome with ring sideroblasts	Enrichment	MT-CO1	2.45
20	Colorectal cancer	Enrichment	MT-CO1, NFE2L2	2.34
21	Tobacco addiction	Enrichment	CYP2A6	2.33
22	Congenital generalized lipodystrophy	Enrichment	FOS	2.33
23	Hereditary recurrent myoglobinuria	Enrichment	MT-CO1	2.33
24	Idiopathic achalasia	Enrichment	NOS1	2.33
25	Histiocytoid hemangioma	Enrichment	FOS	2.23
26	Deafness, nonsyndromic sensorineural, mitochondrial	Enrichment	MT-CO1	2.15
27	Common variable immunodeficiency	Enrichment	NFKB1	2.08
28	Mitochondrial myopathy, infantile, transient	Enrichment	MT-CO1	1.98
29	Ciliary dyskinesia, primary, 3	Enrichment	NFKB1	1.93
30	Familial colorectal cancer	Enrichment	MT-CO1	1.93
31	Mitochondrial myopathy with reversible cytochrome c oxidase deficiency	Enrichment	MT-CO1	1.93
32	Rare mitochondrial non-syndromic sensorineural deafness	Enrichment	MT-CO1	1.93
33	Cox deficiency, benign infantile mitochondrial myopathy	Enrichment	MT-CO1	1.79
34	Gliosarcoma	Enrichment	NFKBIA	1.73
35	Giant cell glioblastoma	Enrichment	NFKBIA	1.70
36	Mitochondrial complex iv deficiency, nuclear type 1	Enrichment	MT-CO1	1.59
37	Tetralogy of fallot	Enrichment	MT-CO1	1.52
38	Mitochondrial complex v deficiency, mitochondrial type 1	Enrichment	MT-CO1	1.52
39	Neuropathy, ataxia, and retinitis pigmentosa	Enrichment	MT-CO1	1.52
40	Striatonigral degeneration, infantile, mitochondrial	Enrichment	MT-CO1	1.52
41	Camptodactyly of fingers	Enrichment	MT-CO1	1.52
42	Severe combined immunodeficiency	Enrichment	IKBKB	1.42
43	Leber hereditary optic neuropathy, modifier of	Enrichment	MT-CO1	1.37
44	Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes	Enrichment	MT-CO1	1.36
45	Hypertelorism	Enrichment	MT-CO1	1.22
46	Leigh syndrome, nuclear	Enrichment	MT-CO1	1.11
47	Breast cancer	Enrichment	JUN	1.07
48	Leigh disease	Enrichment	MT-CO1	1.07
49	Mitochondrial disease	Enrichment	MT-CO1	1.01
50	Leber plus disease	Enrichment	MT-CO1	0.97
51	Retinitis pigmentosa	Enrichment	MT-CO1	0.65

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

Quercetin and Nf-kB / AP-1 induced apoptosis

Pathway Network for Quercetin and Nf-kB / AP-1 induced apoptosis

Member Pathways for Quercetin and Nf-kB / AP-1 induced apoptosis

Pathways in the Quercetin and Nf-kB / AP-1 induced apoptosis SuperPath

Associated Genes for Quercetin and Nf-kB / AP-1 induced apoptosis

Associated Disorders for Quercetin and Nf-kB / AP-1 induced apoptosis

Disorders associated with Quercetin and Nf-kB / AP-1 induced apoptosis SuperPath

STRING Interaction Network for Quercetin and Nf-kB / AP-1 induced apoptosis

Sources for Quercetin and Nf-kB / AP-1 induced apoptosis